Factors Predicting Progression in Patients With Ph+ ALL in Complete Molecular Response Within 3 Months of TKI Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic Factors for Progression in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Complete Molecular Response Within 3 Months of Therapy With Tyrosine Kinase Inhibitors
Cancer 2021 Aug 01;127(15)2648-2656, K Sasaki, HM Kantarjian, NJ Short, B Samra, JD Khoury, R Kanagal Shamanna, M Konopleva, N Jain, CD DiNardo, R Khouri, G Garcia-Manero, TM Kadia, WG Wierda, IF Khouri, P Kebriaei, RS Mehta, RE Champlin, R Garris, CM Cheung, N Daver, PA Thompson, M Yilmaz, F Ravandi, E JabbourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.